LHC Group, Inc. (NASDAQ:LHCG) has been given an average recommendation of “Buy” by the sixteen brokerages that are presently covering the firm, Marketbeat.com reports. Four analysts have rated the stock with a hold recommendation, eleven have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $105.77.

LHCG has been the topic of several recent research reports. Bank of America set a $119.00 price target on shares of LHC Group and gave the company a “buy” rating in a report on Tuesday, September 18th. BidaskClub upgraded shares of LHC Group from a “buy” rating to a “strong-buy” rating in a report on Friday, September 28th. Zacks Investment Research upgraded shares of LHC Group from a “hold” rating to a “buy” rating and set a $106.00 price target for the company in a report on Tuesday, November 6th. Craig Hallum downgraded shares of LHC Group from a “buy” rating to a “hold” rating and cut their price target for the stock from $99.00 to $92.00 in a report on Friday, October 26th. Finally, SunTrust Banks raised their price target on shares of LHC Group to $115.00 and gave the stock a “buy” rating in a report on Thursday, September 13th.

Shares of LHCG stock traded up $1.56 on Friday, reaching $97.10. The stock had a trading volume of 138,760 shares, compared to its average volume of 257,973. The company has a market cap of $3.01 billion, a P/E ratio of 40.12, a price-to-earnings-growth ratio of 1.36 and a beta of 0.88. LHC Group has a 1 year low of $58.65 and a 1 year high of $107.51. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.61 and a quick ratio of 1.61.

LHC Group (NASDAQ:LHCG) last released its quarterly earnings results on Wednesday, October 31st. The health services provider reported $0.95 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.95. The company had revenue of $507.00 million during the quarter, compared to analyst estimates of $515.03 million. LHC Group had a return on equity of 8.23% and a net margin of 3.85%. The firm’s revenue was up 88.0% on a year-over-year basis. During the same quarter last year, the business posted $0.64 earnings per share. As a group, analysts expect that LHC Group will post 3.53 earnings per share for the current year.

In other news, CEO Keith G. Myers sold 6,790 shares of the firm’s stock in a transaction on Monday, January 7th. The shares were sold at an average price of $95.01, for a total value of $645,117.90. Following the sale, the chief executive officer now directly owns 155,475 shares in the company, valued at approximately $14,771,679.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Keith G. Myers sold 75,000 shares of the firm’s stock in a transaction on Tuesday, November 6th. The shares were sold at an average price of $95.10, for a total transaction of $7,132,500.00. Following the completion of the sale, the chief executive officer now owns 200,765 shares in the company, valued at $19,092,751.50. The disclosure for this sale can be found here. Insiders sold a total of 241,821 shares of company stock valued at $23,703,540 in the last three months. 6.80% of the stock is currently owned by corporate insiders.

Several institutional investors and hedge funds have recently made changes to their positions in LHCG. FMR LLC lifted its holdings in shares of LHC Group by 297.8% in the second quarter. FMR LLC now owns 1,151,406 shares of the health services provider’s stock valued at $98,548,000 after purchasing an additional 861,952 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in shares of LHC Group by 2.9% in the third quarter. Bank of New York Mellon Corp now owns 732,075 shares of the health services provider’s stock valued at $75,394,000 after purchasing an additional 20,567 shares in the last quarter. Northern Trust Corp lifted its holdings in shares of LHC Group by 51.7% in the second quarter. Northern Trust Corp now owns 572,094 shares of the health services provider’s stock valued at $48,966,000 after purchasing an additional 194,902 shares in the last quarter. Waddell & Reed Financial Inc. lifted its holdings in shares of LHC Group by 4.6% in the second quarter. Waddell & Reed Financial Inc. now owns 526,400 shares of the health services provider’s stock valued at $45,055,000 after purchasing an additional 23,200 shares in the last quarter. Finally, Thrivent Financial for Lutherans lifted its holdings in shares of LHC Group by 14.0% in the third quarter. Thrivent Financial for Lutherans now owns 486,243 shares of the health services provider’s stock valued at $50,078,000 after purchasing an additional 59,816 shares in the last quarter. Institutional investors and hedge funds own 87.79% of the company’s stock.

About LHC Group

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.

Featured Story: Rule of 72

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.